株式会社マルコム（本社：東京都渋谷区、代表取締役原田 学）は新型コロナウイルス抗体（IgM/IgG）を同時に15分で判定が ...
株式会社ヤマジ(本社：岐阜県関市、代表取締役：北島多美子)は、世界各国で認証され、全体一致率95.14％の新型コロナ ...
The current COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus that causes severe acute respiratory distress in a significant proportion of ...
Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 in Wuhan, China, and rapidly progressed into a devastating pandemic affecting ...
Researchers at UMC Utrecht have discovered that converting monoclonal antibodies from the IgG to the IgM isotype can significantly broaden their ability to recognize and bind multiple human-relevant ...
－30年以上不明だったIgM抗体の受容体の遺伝子が明らかに－ 独立行政法人理化学研究所（野依良治理事長）は、風邪ウイルスや細菌などの異物に対する自然免疫※1 や初期の感染防御に必須な、免疫グロブリンM（IgM抗体※2 ）の受容体の遺伝子を世界で ...
A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal ...
SUGENTECH's COVID-19 IgM&IgG 5-10 minutes rapid test kit is listed on the U.S. FDA's database and can be used in the U.S., as stated in Section IV.D of the FDA's Policy for Diagnostic Tests for ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する